Online citations, reference lists, and bibliographies.
← Back to Search

Incidence And Familial Risk Of Pleural Mesothelioma In Sweden: A National Cohort Study

J. Ji, J. Sundquist, K. Sundquist
Published 2016 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Familial clustering of pleural mesothelioma was reported previously, but none of the reports quantified the familial risk of mesothelioma or the association with other cancers. The contributions of shared environmental or genetic factors to the aggregation of mesothelioma were unknown. We used a number of Swedish registers, including the Swedish Multigeneration Register and the Swedish Cancer Register, to examine the familial risk of mesothelioma in offspring. Standardised incidence ratios (SIRs) were used to calculate the risk. Age standardised incidence rates of mesothelioma were calculated from the Swedish Cancer Registry. The incidence of mesothelioma reached its peak rate in 2000 and decreased thereafter. Risk of mesothelioma was significantly increased when parents or siblings were diagnosed with mesothelioma, with SIRs of 3.88 (95% CI 1.01–10.04) and 12.37 (95% CI 5.89–22.84), respectively. Mesothelioma was associated with kidney (SIR 2.13, 95% CI 1.16–3.59) and bladder cancers (SIR 2.09, 95% CI 1.32–3.14) in siblings. No association was found between spouses. Family history of mesothelioma, including both parental and sibling history, is an important risk factor for mesothelioma. Shared genetic factors may contribute to the observed familial clustering of mesothelioma, but the contribution of shared environmental factors could not be neglected. The association with kidney and bladder cancers calls for further study to explore the underlying mechanisms. Mesothelioma in Sweden began to decrease after 2000; family history is a risk factor for mesothelioma http://ow.ly/4mJemg
This paper references
10.1007/s00432-007-0327-5
Familial risk for soft tissue tumors: a nation-wide epidemiological study from Sweden
J. Ji (2007)
10.1136/oem.56.2.110
Pleural mesothelioma in Sweden: an analysis of the incidence according to the use of asbestos.
B. Järvholm (1999)
10.1016/J.EJCA.2005.11.043
Familial risk for histology-specific bone cancers: an updated study in Sweden.
J. Ji (2006)
10.1016/j.ijcard.2013.03.149
Shared and non-shared familial susceptibility of coronary heart disease, ischemic stroke, peripheral artery disease and aortic disease.
S. Calling (2013)
10.1097/CEJ.0000000000000101
Contribution of shared environmental factors to familial aggregation of common cancers: an adoption study in Sweden.
K. Sundquist (2015)
10.1016/j.ejca.2009.10.009
Cancer incidence among Iranian immigrants in Sweden and Iranian residents compared to the native Swedish population.
Seyed Mohsen Mousavi (2010)
10.1677/ERC-09-0284
Histology-specific risks in testicular cancer in immigrants to Sweden.
K. Hemminki (2010)
10.1016/J.CGH.2006.03.005
Familial risk for esophageal cancer: an updated epidemiologic study from Sweden.
J. Ji (2006)
10.1016/S0140-6736(00)04013-7
Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey
Iman Roushdy-Hammady (2001)
10.1016/j.mrrev.2008.02.002
Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases.
M. Neri (2008)
10.1054/bjoc.2000.1585
Sibling risks in cancer: clues to recessive or X-linked genes?
K. Hemminki (2001)
10.1038/sj.bjc.6604879
Occupational, domestic and environmental mesothelioma risks in the British population: a case–control study
C. Rake (2009)
10.1158/0008-5472.CAN-15-0295
Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer.
J. Ohar (2016)
10.1590/S1806-37132014000500018
Resposta dos autores
L. D. Assis (2014)
10.1093/carcin/bgv097
Gene-asbestos interaction in malignant pleural mesothelioma susceptibility.
S. Tunesi (2015)
10.1002/ijc.27758
Familial aggregation of malignant mesothelioma in former workers and residents of Wittenoom, Western Australia
N. de Klerk (2013)
10.1073/pnas.1213238109
High prevalence of serum antibodies reacting with simian virus 40 capsid protein mimotopes in patients affected by malignant pleural mesothelioma
E. Mazzoni (2012)
10.1136/thoraxjnl-2013-203744
Occupational and non-occupational attributable risk of asbestos exposure for malignant pleural mesothelioma
A. Lacourt (2014)
Cancer mortality and incidence of mesothelioma in a cohort of wives of asbestos workers in Casale Monferrato
D Ferrante (2007)
10.1684/BDC.2007.0407
Mésothéliomes familiaux : une composante génétique associée aux risques environnementaux ?
B. You (2007)
10.1002/ijc.10806
Mesothelioma incidence seems to have leveled off in Sweden
K. Hemminki (2003)
10.1700/1088.11931
Asbestos and SV40 in malignant pleural mesothelioma from a hyperendemic area of north-eastern Italy.
M. Comar (2012)
10.1136/oem.51.4.244
Pleural mesothelioma and exposure to asbestos: evaluation from work histories and analysis of asbestos bodies in bronchoalveolar lavage fluid or lung tissue in 131 patients.
J. Pairon (1994)
10.1016/j.humpath.2015.06.024
BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma.
Stephanie M. McGregor (2015)
10.1136/oemed-2013-101957
High incidence of lung cancer and malignant mesothelioma linked to erionite fibre exposure in a rural community in Central Mexico
M. A. Ortega-Guerrero (2014)
10.1002/ijc.22590
Polymorphisms of glutathione‐S‐transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma
S. Landi (2007)
The development of MM is strongly correlated with exposure to asbestos and erionite, as well as to simian virus 40”.
L. D. Assis (2014)
10.1002/ijc.23230
Mesothelioma incidence has leveled off in Sweden
K. Hemminki (2008)
10.1016/S0140-6736(78)90911-X
NON-OCCUPATIONAL EXPOSURE TO ASBESTOS AND MALIGNANT MESOTHELIOMA IN FEMALES
N. Vianna (1978)
10.1289/ehp.10195
Cancer Mortality and Incidence of Mesothelioma in a Cohort of Wives of Asbestos Workers in Casale Monferrato, Italy
D. Ferrante (2007)
10.1093/annonc/mdt135
Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation.
C. Ribeiro (2013)
10.1016/j.ijheh.2008.08.001
Pooled analysis of NAT2 genotypes as risk factors for asbestos-related malignant mesothelioma.
M. Betti (2009)
10.1016/j.juro.2015.07.113
Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression.
R. Joseph (2016)
10.1177/1403494815596500
Emerging evidence that the ban on asbestos use is reducing the occurrence of pleural mesothelioma in Sweden
B. Järvholm (2015)
10.1056/NEJMRA050152
Advances in malignant mesothelioma.
B. Robinson (2005)
10.1093/ANNONC/MDM092
Familial blood vessel tumors and subsequent cancers.
J. Ji (2007)
10.1136/bmj.e8076
Familial risk of early and late onset cancer: nationwide prospective cohort study
E. Kharazmi (2012)
10.1002/ijc.27462
Comparability of cancer identification among Death Registry, Cancer Registry and Hospital Discharge Registry
J. Ji (2012)
10.1136/oem.48.1.48
Occupational exposure to asbestos as evaluated from work histories and analysis of lung tissues from patients with mesothelioma.
T. Tuomi (1991)



This paper is referenced by
10.1183/13993003.00953-2019
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
A. Scherpereel (2020)
10.7196/SARJ.2019.V25I2.230
A series of patients with unusual lung cancers with unusual presentations
Dineo Maphanga (2019)
10.1183/13993003.02384-2017
Variation in incidence trends of malignant pleural mesothelioma in Europe
M. Ahmed (2018)
10.1053/j.jvca.2020.07.017
The 2019 ERS/ESTS/EACTS/ESTRO Guidelines on the Management of Patients With Malignant Pleural Mesothelioma.
T. Gelzinis (2020)
10.3389/fgene.2018.00232
Pre-clinical Models for Malignant Mesothelioma Research: From Chemical-Induced to Patient-Derived Cancer Xenografts
Noushin Nabavi (2018)
Malignant pleural mesothelioma : recognising an unmet need
Samal Gunatilake (2018)
10.1183/13993003.00085-2017
Rare respiratory diseases are ready for primetime: from Rare Disease Day to the European Reference Networks
M. Humbert (2017)
10.1093/ejcts/ezaa158
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma.
I. Opitz (2020)
10.1007/s10552-016-0838-y
Incidence of malignant mesothelioma in Germany 2009–2013
Martin Lehnert (2016)
10.1136/bcr-2018-227882
A case from India of pleural malignant mesothelioma probably due to domestic and environmental asbestos exposure: a posthumous report
V. Muralidhar (2019)
10.1053/j.gastro.2019.05.012
Use of Phosphodiesterase 5 Inhibitors Associates With Risk of Colorectal Cancer in Men With Benign Colorectal Neoplasms.
Wuqing Huang (2019)
10.1016/j.ejca.2018.07.139
Familial risk of pleural mesothelioma increased drastically in certain occupations: A nationwide prospective cohort study.
E. Kharazmi (2018)
What's new in mesothelioma.
V. Ascoli (2018)
Mesotelioma pleural maligno. Actualización sobre diagnóstico y tratamiento
Giselle Gómez Trueba (2020)
10.1007/s13665-019-0224-9
Malignant Pleural Mesothelioma: an Update for Pulmonologists
C. Sidhu (2019)
Semantic Scholar Logo Some data provided by SemanticScholar